Extendicare Inc
TSX:EXE

Watchlist Manager
Extendicare Inc Logo
Extendicare Inc
TSX:EXE
Watchlist
Price: 10.38 CAD 0.39% Market Closed
Market Cap: 866.4m CAD
Have any thoughts about
Extendicare Inc?
Write Note

Wall Street
Price Targets

EXE Price Targets Summary
Extendicare Inc

Wall Street analysts forecast EXE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EXE is 10.71 CAD with a low forecast of 9.6 CAD and a high forecast of 12.08 CAD.

Lowest
Price Target
9.6 CAD
8% Downside
Average
Price Target
10.71 CAD
3% Upside
Highest
Price Target
12.08 CAD
16% Upside
Extendicare Inc Competitors:
Price Targets
IHH
IHH Healthcare Bhd
10% Upside
ARV
Arvida Group Ltd
3% Upside
HEAL
Medikaloka Hermina Tbk PT
29% Upside
APOLLOHOSP
Apollo Hospitals Enterprise Ltd
15% Upside
CON
Concentra Group Holdings Parent Inc
30% Upside
MIKA
Mitra Keluarga Karyasehat Tbk PT
28% Upside
4017
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
13% Upside
RJH
Rajthanee Hospital PCL
19% Upside

Revenue
Forecast

Revenue Estimate
Extendicare Inc

For the last 8 years the compound annual growth rate for Extendicare Inc's revenue is 4%. The projected CAGR for the next 3 years is 5%.

4%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Extendicare Inc

For the last 8 years the compound annual growth rate for Extendicare Inc's operating income is 1%. The projected CAGR for the next 5 years is -43%.

1%
Past Growth
-43%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Extendicare Inc

For the last 8 years the compound annual growth rate for Extendicare Inc's net income is -21%. The projected CAGR for the next 3 years is 10%.

-21%
Past Growth
10%
Estimated Growth
Estimates Accuracy
48%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EXE's stock price target?
Price Target
10.71 CAD

According to Wall Street analysts, the average 1-year price target for EXE is 10.71 CAD with a low forecast of 9.6 CAD and a high forecast of 12.08 CAD.

What is Extendicare Inc's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Extendicare Inc's revenue is 4%. The projected CAGR for the next 3 years is 5%.

What is Extendicare Inc's Operating Income forecast?
Projected CAGR
-43%

For the last 8 years the compound annual growth rate for Extendicare Inc's operating income is 1%. The projected CAGR for the next 5 years is -43%.

What is Extendicare Inc's Net Income forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Extendicare Inc's net income is -21%. The projected CAGR for the next 3 years is 10%.

Back to Top